December #130 : High Definitions - by Bob Lederer

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

On the Cover-William 'Billy' Dickerson

35 Ones To Watch




High Definitions

Women on the Verge

Free At Last

Sins Of The Flesh

Poster Children

Trainer’s Bench-December 2006

Star Quality




Madonna Dearest

We’re Not In Kansas Anymore

Recipe for Disaster

Signing Bonus

Pick Your Poison

The Bug Stops Here




Editor's Letter-December 2006

Mailbox-December 2006

Catch Of The Month-December 2006



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

December 2006


High Definitions

by Bob Lederer

You walk the walk; now talk the talk with this vital med lingo

Watch your language: Two trailblazing drugs will expand your treatment choices—and your vocabulary. FDA approval could be around the corner for two new entry inhibitor (EI) meds: maraviroc and vicriviroc. What’s an EI, you ask? While nukes, non-nukes and protease inhibitors mess with HIV after it invades your CD4 immune cells, EIs stop the virus from entering at all. The new pills will latch onto receptors on the surface of CD4 cells, blocking HIV. But the virus can attach to two different CD4 receptors; which one it chooses can affect how an EI works for you. The following terms will soon be as familiar as “CD4 cells” and “viral load.” Study up, and they—and your doctor—will start making sense.

CCR5 and CXCR4; “R5” and “X4” for short: the receptors on CD4 cells.

Tropism (or tropic): HIV’s tendency to use one or the other receptor to enter CD4s.

R5-tropic; X4-tropic: HIV that uses CCR5 or CXCR4. Virus in people with advanced AIDS (and maybe earlier) may switch from the R5 receptor to the X4. Whether this is a cause or an effect of disease progression is unknown.

Mixed-tropic: pool of HIV that includes R5- and X4-tropic viruses.

Dual-tropic: HIV that can use R5 or X4.Maraviroc and vicriviroc target only R5-tropic HIV, but data suggest that they could benefit people with mixed-tropic virus. And while some studies show that HIV can switch from R5 to X4 with these drugs, disease progression hasn’t accelerated. Meanwhile, researchers are working toward EIs that target X4-tropic virus. Word.  


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.